Authors:
Haase, CG
Guggenmos, J
Brehm, U
Andersson, M
Olsson, T
Reindl, M
Schneidewind, JM
Zettl, UK
Heidenreich, F
Berger, T
Wekerle, H
Hohlfeld, R
Linington, C
Citation: Cg. Haase et al., The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls, J NEUROIMM, 114(1-2), 2001, pp. 220-225
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, HP
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Deisenhammer, F
Freimuller, M
Hartung, HP
Kollegger, H
Kristoferitsch, W
Lassmann, H
Markut, H
Vass, K
Altenkirch, H
Boese, J
Gass, A
Gehlen, W
Goebels, N
Haas, J
Haferkamp, G
Heidenreich, F
Heitmann, R
Hemmer, B
Hohlfeld, R
Janzen, RWC
Jugelt, E
Kolmel, W
Konig, N
Kowitzsch, K
Manegold, U
Melms, A
Mertin, J
Petereit, HF
Pette, M
Pohlau, D
Poser, S
Sailer, M
Schmidt, S
Schock, G
Schulz, M
Seidel, D
Stangel, M
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, UK
Zipp, F
Zschenderlein, R
Bayas, A
Chan, A
Flachenecker, P
Gold, R
Grauer, O
Jung, S
Kallmann, B
Leussink, V
Maurer, M
Rieckmann, P
Toyka, KV
Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157
Authors:
Windhagen, A
Maniak, S
Marckmann, S
Wilkening, A
Lindert, RB
Heidenreich, F
Blasczyk, R
Citation: A. Windhagen et al., Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate, J NE NE PSY, 70(3), 2001, pp. 415-416
Authors:
Rades, D
Heidenreich, F
Bremer, M
Karstens, JH
Citation: D. Rades et al., Time of developing motor deficits before radiotherapy as a new and relevant prognostic factor in metastatic spinal cord compression: Final results ofa retrospective analysis, EUR NEUROL, 45(4), 2001, pp. 266-269
Authors:
Jacobsen, M
Schweer, D
Ziegler, A
Gaber, R
Schock, S
Schwinzer, R
Wonigeit, K
Lindert, RB
Kantarci, O
Schaefer-Klein, J
Schipper, HI
Oertel, WH
Heidenreich, F
Weinshenker, BG
Sommer, N
Hemmer, B
Citation: M. Jacobsen et al., A point mutation in PTPRC is associated with the development of multiple sclerosis, NAT GENET, 26(4), 2000, pp. 495-499
Authors:
Rades, D
Blach, M
Bremer, M
Wildfang, I
Karstens, JH
Heidenreich, F
Citation: D. Rades et al., Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: One-year results of a prospective trial, INT J RAD O, 48(5), 2000, pp. 1403-1408
Authors:
Klein, M
Heidenreich, F
Madjlessi, F
Granetzny, A
Dauben, HP
Schulte, HD
Gams, E
Citation: M. Klein et al., Early and late results after thymectomy in myasthenia gravis: a retrospective study (vol 47, pg 170, 1999), THOR CARD S, 48(1), 2000, pp. 64-64
Authors:
Kracke, A
von Wussow, P
Al-Masri, AN
Dalley, G
Windhagen, A
Heidenreich, F
Citation: A. Kracke et al., Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS, NEUROLOGY, 54(1), 2000, pp. 193-199
Authors:
Aulkemeyer, P
Hausner, G
Brinkmeier, H
Weber, F
Wurz, A
Heidenreich, F
Rudel, R
Citation: P. Aulkemeyer et al., The small sodium-channel blocking factor in the cerebrospinal fluid of multiple sclerosis patients is probably an oligopeptide, J NEUR SCI, 172(1), 2000, pp. 49-54
Citation: A. Windhagen et al., Analysis of cerebrospinal fluid cells by flow cytometry and immunocytochemistry in inflammatory central nervous system diseases: Comparison of low- and high-density cell surface antigen expression, DIAGN CYTOP, 21(5), 1999, pp. 313-318
Authors:
Lichtinghagen, R
Seifert, T
Kracke, A
Marckmann, S
Wurster, U
Heidenreich, F
Citation: R. Lichtinghagen et al., Expression of matrix metalloproteinase-9 and its inhibitors in mononuclearblood cells of patients with multiple sclerosis, J NEUROIMM, 99(1), 1999, pp. 19-26
Authors:
Windhagen, A
Maniak, S
Gebert, A
Ferger, I
Heidenreich, F
Citation: A. Windhagen et al., Costimulatory molecules B7-1 and B7-2 on CSF cells in multiple sclerosis and optic neuritis, J NEUROIMM, 96(1), 1999, pp. 112-120